Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Titel:
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Auteur:
Azzouzi, Abdel-Rahmène Vincendeau, Sébastien Barret, Eric Cicco, Antony Kleinclauss, François van der Poel, Henk G Stief, Christian G Rassweiler, Jens Salomon, Georg Solsona, Eduardo Alcaraz, Antonio Tammela, Teuvo T Rosario, Derek J Gomez-Veiga, Francisco Ahlgren, Göran Benzaghou, Fawzi Gaillac, Bertrand Amzal, Billy Debruyne, Frans M J Fromont, Gaëlle Gratzke, Christian Emberton, Mark